Author:
Barash Joshua H.,Hillson Christina,Buchanan Edward,Suaray Mafudia
Reference36 articles.
1. Weström L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Obstet Gynecol. 1980;138(7 Pt 2):880.
2. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201 Suppl 2:S134–55.
3. Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985–2001. Sex Transm Dis. 2005;32(12):778.
4. Niruthisard S, Chutivongse S, Roddy R. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet. 1992;339(8806):1371–5.
5. Flesh G, Weiner J, Corlett Jr R, Boice C, Mishell Jr D, Wolf R. The intrauterine contraceptive device and acute salpingitis: a multifactor analysis. Obstet Gynecol. 1979;135(3):402.